CSIR - IMTECH partner with Zydus Cadila

For development of newer drugs for drug resistant infectious diseases
The Council of Scientific and Industrial Research (CSIR) - Institute of Microbial Technology (IMTECH), a premier microbial institute under the aegis of the Ministry of Science and Technology, Government of India, recently signed a collaborative research agreement with Zydus Cadila, an innovation-driven global healthcare group. The research partnership will primarily aim to identify new drug candidates for treatment of drug-resistant infections.The agreement between CSIR-IMTECH and Zydus will see scientists from both organizations working closely together on microbiology & genomics to identify new lead candidate as novel anti-tuberculosis compounds. For this project, scientists at IMTECH will utilize their expertise and scientific knowledge in microbiology while Zydus Cadila will provide its expertise in medicinal chemistry & pharmaceutical drug development with an aim to develop new drug combinations against drug-resistant pathogens which causes severe diseases in India and across the world.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 05 2018 | 12:01 PM IST
